Au WW - Search Results

1

GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.

Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. Abdel-Rahman SZ, et al. Among authors: au ww. Cancer Detect Prev. 1998;22(2):129-38. doi: 10.1046/j.1525-1500.1998.00934.x. Cancer Detect Prev. 1998. PMID: 9544433

2

Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.

Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM, Au WW. Anwar WA, et al. Among authors: au ww. Carcinogenesis. 1996 Sep;17(9):1923-9. doi: 10.1093/carcin/17.9.1923. Carcinogenesis. 1996. PMID: 8824515

3

A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies.

Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW. Abdel-Rahman SZ, et al. Among authors: au ww. Cancer Lett. 1996 Oct 22;107(2):229-33. doi: 10.1016/0304-3835(96)04832-x. Cancer Lett. 1996. PMID: 8947518

4

Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma.

El-Zein RA, Zwischenberger JB, Abdel-Rahman SZ, Sankar AB, Au WW. El-Zein RA, et al. Among authors: au ww. Cancer Lett. 1997 Jan 15;112(1):71-8. doi: 10.1016/S0304-3835(96)04547-8. Cancer Lett. 1997. PMID: 9029171

5

Combined genetic polymorphism and risk for development of lung cancer.

el-Zein R, Zwischenberger JB, Wood TG, Abdel-Rahman SZ, Brekelbaum C, Au WW. el-Zein R, et al. Among authors: au ww. Mutat Res. 1997 Nov 28;381(2):189-200. doi: 10.1016/s0027-5107(97)00166-8. Mutat Res. 1997. PMID: 9434875

6

Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers.

Abdel-Rahman SZ, El-Zein RA, Zwischenberger JB, Au WW. Abdel-Rahman SZ, et al. Among authors: au ww. Mutat Res. 1998 Feb 26;398(1-2):43-54. doi: 10.1016/s0027-5107(97)00238-8. Mutat Res. 1998. PMID: 9626964

7

Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity.

Salama SA, Abdel-Rahman SZ, Sierra-Torres CH, Hamada FA, Au WW. Salama SA, et al. Among authors: au ww. Pharmacogenetics. 1999 Dec;9(6):735-43. Pharmacogenetics. 1999. PMID: 10634136

8

The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer.

Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Ghoneim MA, Au WW. Abdel-Rahman SZ, et al. Among authors: au ww. Cancer Lett. 1997 Oct 28;119(1):115-22. doi: 10.1016/s0304-3835(97)00265-6. Cancer Lett. 1997. PMID: 18372530

9

Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers.

Conforti-Froes N, el-Zein R, Abdel-Rahman SZ, Zwischenberger JB, Au WW. Conforti-Froes N, et al. Among authors: au ww. Mutat Res. 1997 Sep 5;379(1):53-9. doi: 10.1016/s0027-5107(97)00106-1. Mutat Res. 1997. PMID: 9330622

10

Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.

Abdel-Rahman SZ, Salama SA, Au WW, Hamada FA. Abdel-Rahman SZ, et al. Among authors: au ww. Pharmacogenetics. 2000 Apr;10(3):239-49. doi: 10.1097/00008571-200004000-00005. Pharmacogenetics. 2000. PMID: 10803680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters